Cargando…
Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19
INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a newly recognized infectious disease that has spread rapidly. COVID-19 has been associated with a number of cardiovascular complications, including arrhythmias. The mechanism of ventricular arrhythmias in patients with COVID-19 is uncertain. The...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373019/ https://www.ncbi.nlm.nih.gov/pubmed/32731139 http://dx.doi.org/10.1016/j.jelectrocard.2020.07.005 |
_version_ | 1783561425838407680 |
---|---|
author | Yenerçağ, Mustafa Arslan, Uğur Doğduş, Mustafa Günal, Özgür Öztürk, Çağatay Erman Aksan, Gökhan Erdoğan, Güney Gül, Sefa Yontar, Osman Can Şen, Ahmet |
author_facet | Yenerçağ, Mustafa Arslan, Uğur Doğduş, Mustafa Günal, Özgür Öztürk, Çağatay Erman Aksan, Gökhan Erdoğan, Güney Gül, Sefa Yontar, Osman Can Şen, Ahmet |
author_sort | Yenerçağ, Mustafa |
collection | PubMed |
description | INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a newly recognized infectious disease that has spread rapidly. COVID-19 has been associated with a number of cardiovascular complications, including arrhythmias. The mechanism of ventricular arrhythmias in patients with COVID-19 is uncertain. The aim of the present study was to evaluate the ventricular repolarization by using the Tp-e interval, QT dispersion, Tp-e/QT ratio, and Tp-e/QTc ratio as candidate markers of ventricular arrhythmias in patients with newly diagnosed COVID-19. In addition, the relationship between the repolarization parameters and the CRP (C-reactive protein) was investigated. METHODS: 75 newly diagnosed COVID-19 patients, 75 age and sex matched healthy subjects were included in the study between 20th March 2020 and 10th April 2020. The risk of ventricular arrhythmias was evaluated by calculating the electrocardiographic Tp-e and QT interval, Tp-e dispersion, corrected QT(QTc), QT dispersion (QTd), corrected QTd, Tp-e/QT and Tp-e/QTc ratios. CRP values were also measured in patients with newly diagnosed COVID-19. RESULTS: Tp-e interval (80.7 ± 4.6 vs. 70.9 ± 4.8; p < .001), Tp-e / QT ratio (0.21 ± 0.01 vs. 0.19 ± 0.01; p < .001) and Tp-e/QTc ratio (0.19 ± 0.01 vs.0.17 ± 0.01; p < .001) were significantly higher in patients with newly diagnosed COVID-19 than the control group. There was a significant positive correlation between Tp-e interval, Tp-e/QTc ratio and CRP in patients with newly diagnosed COVID-19 (rs = 0.332, p = .005, rs = 0.397, p < .001 consecutively). During their treatment with hydroxychloroquine (HCQ), azithromycin and favipiravir, ventricular tachycardia episodes were observed in in two COVID-19 patients during their hospitalization in the intensive care unit. CONCLUSION: Our study showed for the first time in literature that the Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio, which are evaluated electrocardiographically in patients with newly diagnosed COVID-19, were prolonged compared with normal healthy individuals. A positive correlation was determined between repolarization parameters and CRP. We believe that pre-treatment evaluation of repolarization parameters in newly diagnosed COVID-19 would be beneficial for predicting ventricular arrhythmia risk. |
format | Online Article Text |
id | pubmed-7373019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73730192020-07-22 Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19 Yenerçağ, Mustafa Arslan, Uğur Doğduş, Mustafa Günal, Özgür Öztürk, Çağatay Erman Aksan, Gökhan Erdoğan, Güney Gül, Sefa Yontar, Osman Can Şen, Ahmet J Electrocardiol Article INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a newly recognized infectious disease that has spread rapidly. COVID-19 has been associated with a number of cardiovascular complications, including arrhythmias. The mechanism of ventricular arrhythmias in patients with COVID-19 is uncertain. The aim of the present study was to evaluate the ventricular repolarization by using the Tp-e interval, QT dispersion, Tp-e/QT ratio, and Tp-e/QTc ratio as candidate markers of ventricular arrhythmias in patients with newly diagnosed COVID-19. In addition, the relationship between the repolarization parameters and the CRP (C-reactive protein) was investigated. METHODS: 75 newly diagnosed COVID-19 patients, 75 age and sex matched healthy subjects were included in the study between 20th March 2020 and 10th April 2020. The risk of ventricular arrhythmias was evaluated by calculating the electrocardiographic Tp-e and QT interval, Tp-e dispersion, corrected QT(QTc), QT dispersion (QTd), corrected QTd, Tp-e/QT and Tp-e/QTc ratios. CRP values were also measured in patients with newly diagnosed COVID-19. RESULTS: Tp-e interval (80.7 ± 4.6 vs. 70.9 ± 4.8; p < .001), Tp-e / QT ratio (0.21 ± 0.01 vs. 0.19 ± 0.01; p < .001) and Tp-e/QTc ratio (0.19 ± 0.01 vs.0.17 ± 0.01; p < .001) were significantly higher in patients with newly diagnosed COVID-19 than the control group. There was a significant positive correlation between Tp-e interval, Tp-e/QTc ratio and CRP in patients with newly diagnosed COVID-19 (rs = 0.332, p = .005, rs = 0.397, p < .001 consecutively). During their treatment with hydroxychloroquine (HCQ), azithromycin and favipiravir, ventricular tachycardia episodes were observed in in two COVID-19 patients during their hospitalization in the intensive care unit. CONCLUSION: Our study showed for the first time in literature that the Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio, which are evaluated electrocardiographically in patients with newly diagnosed COVID-19, were prolonged compared with normal healthy individuals. A positive correlation was determined between repolarization parameters and CRP. We believe that pre-treatment evaluation of repolarization parameters in newly diagnosed COVID-19 would be beneficial for predicting ventricular arrhythmia risk. Elsevier Inc. 2020 2020-07-21 /pmc/articles/PMC7373019/ /pubmed/32731139 http://dx.doi.org/10.1016/j.jelectrocard.2020.07.005 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Yenerçağ, Mustafa Arslan, Uğur Doğduş, Mustafa Günal, Özgür Öztürk, Çağatay Erman Aksan, Gökhan Erdoğan, Güney Gül, Sefa Yontar, Osman Can Şen, Ahmet Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19 |
title | Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19 |
title_full | Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19 |
title_fullStr | Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19 |
title_full_unstemmed | Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19 |
title_short | Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19 |
title_sort | evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373019/ https://www.ncbi.nlm.nih.gov/pubmed/32731139 http://dx.doi.org/10.1016/j.jelectrocard.2020.07.005 |
work_keys_str_mv | AT yenercagmustafa evaluationofelectrocardiographicventricularrepolarizationvariablesinpatientswithnewlydiagnosedcovid19 AT arslanugur evaluationofelectrocardiographicventricularrepolarizationvariablesinpatientswithnewlydiagnosedcovid19 AT dogdusmustafa evaluationofelectrocardiographicventricularrepolarizationvariablesinpatientswithnewlydiagnosedcovid19 AT gunalozgur evaluationofelectrocardiographicventricularrepolarizationvariablesinpatientswithnewlydiagnosedcovid19 AT ozturkcagatayerman evaluationofelectrocardiographicventricularrepolarizationvariablesinpatientswithnewlydiagnosedcovid19 AT aksangokhan evaluationofelectrocardiographicventricularrepolarizationvariablesinpatientswithnewlydiagnosedcovid19 AT erdoganguney evaluationofelectrocardiographicventricularrepolarizationvariablesinpatientswithnewlydiagnosedcovid19 AT gulsefa evaluationofelectrocardiographicventricularrepolarizationvariablesinpatientswithnewlydiagnosedcovid19 AT yontarosmancan evaluationofelectrocardiographicventricularrepolarizationvariablesinpatientswithnewlydiagnosedcovid19 AT senahmet evaluationofelectrocardiographicventricularrepolarizationvariablesinpatientswithnewlydiagnosedcovid19 |